The out of pocket cost of breast cancer survivors: a review.
BACKGROUND
Out of pocket (OOP) costs add to the burden facing breast cancer survivors but remain an understudied area of costs. Current turbulent economic climate increases the urgency to better understand this burden. Few studies or systematic reviews focus on OOP costs.


METHODS
PubMed search was conducted for articles in English containing: (1) MESH terms breast neoplasms and economics, and (2) words "breast cancer" and "cost" or "costs," "expenditure," or "out of pocket." Limits included: publication dates from January 1, 1980 to December 16, 2009, and populations aged > or = 45 years old. Articles were excluded based on title, abstract, and full text reviews. Citation searches and searches of reference lists were also conducted. Three articles were selected for this review.


RESULTS
Medical direct OOP costs (e.g., for physician fees) ranged from $300 to $1,180 per month during active treatment, and were about $500 per month 1 year post diagnosis. Non-medical direct OOP costs (e.g., for transportation to doctor's office, parking etc.) ranged from $137 to $174 per month in the year post diagnosis; and $200-$509 per month 1 year or more after diagnosis. Different types of costs were identified.


CONCLUSIONS
OOP costs represent a significant burden for survivors even after initial treatment. The nature and extent of OOP costs need further evaluation.


CONCLUSIONS
OOP costs are rarely considered. However, as OOP costs affect the well being of cancer survivors, they should be understood more fully and possibly addressed in interventions aimed at improving quality of life.
Pisu
Maria
M
University of Alabama at Birmingham, USA. mpisu@uab.edu
Azuero
Andres
A
McNees
Patrick
P
Burkhardt
Jeffrey
J
Benz
Rachel
R
Meneses
Karen
K
D001943:Breast Neoplasms / Q000191:economics*; D017281:Cost of Illness; D005260:Female; D006801:Humans; D017741:Survivors
Pharmacoeconomics. 2009;27(3):199-209
19354340
Cancer Invest. 2007 Feb;25(1):47-54
17364557
Cancer Nurs. 1999 Oct;22(5):389-96
10526432
J Health Econ. 2002 Sep;21(5):757-79
12349881
Psychooncology. 2007 Dec;16(12):1130-9
17345557
Cancer Pract. 1998 May-Jun;6(3):182-7
9652250
Eur J Cancer Care (Engl). 2007 Nov;16(6):500-7
17944764
J Health Care Poor Underserved. 2009 Aug;20(3):721-8
19648700
J Natl Cancer Inst. 2008 May 7;100(9):630-41
18445825
J Clin Oncol. 2007 Jan 10;25(2):228-32
17210945
Clin J Oncol Nurs. 2004 Jun;8(3):279-87
15208822
Health Serv Res. 2002 Oct;37(5):1309-28
12479498
Cancer Pract. 2002 Sep-Oct;10(5):248-55
12236838
Women Health. 2002;36(1):1-20
12215000
Psychooncology. 2005 May;14(5):351-60
15386763
Pediatr Nurs. 1992 May-Jun;18(3):285-8
1625958
Oncol Nurs Forum. 2007 Sep;34(5):1007-16
17878129
J Support Oncol. 2004 May-Jun;2(3):271-8
15328826
J Natl Cancer Inst. 2007 Jan 3;99(1):14-23
17202109
Palliat Med. 2007 Oct;21(7):595-607
17942498
Cancer Pract. 1994 May-Jun;2(3):187-93
8055022
Cancer. 2008 Feb 1;112(3):616-25
18085642
Value Health. 2004 Mar-Apr;7(2):186-94
15164808
Am J Manag Care. 2009 Nov;15(11):801-6
19895184
Cancer Nurs. 2008 Nov-Dec;31(6):470-7
18987515
Oncol Nurs Forum. 1998 Oct;25(9):1615-22
9802056
Qual Life Res. 2010 Mar;19(2):177-89
20094806